"It is our mission to provide reliable clinical data to help advance new medical treatments. Established in 1992, we have become one of the most reputable clinical research centers in the area. Leading and upcoming pharmaceutical companies have trusted and allowed us to be a part of their compound development and clinical studies to be conducted in a most professional and ethical manner. Through this process, we are granted the opportunity to help the people of our community to improve their quality of life in maintaining dignity and respect as well as Health Care Providers and the general public in having access to promising new medical treatment and technologies."

During the past decade, MediSphere Medical Research Center, LLC conducted 48 clinical trials. In the 10-year time frame, 48 clinical trials started and 50 clinical trials were completed, i.e. on average, 104.2% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 38 clinical trials were completed. i.e. 190% of trials that started reached the finish line.

Out of the total clinical trials conducted in "MediSphere Medical Research Center, LLC" #1 sponsor was "Pfizer" with 15 trials, followed by "Allergan" with 5 trials sponsored, "Purdue Pharma LP" with 5 trials sponsored, "Shire" with 5 trials sponsored and "Celgene" with 5 trials sponsored. Other sponsors include 61 different institutions and companies that sponsored additional 55 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "MediSphere Medical Research Center, LLC" #1 collaborator was "Camurus AB" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Institut de Recherches Internationales Servier" with 1 trials as a collaborator, "Integrium" with 1 trials as a collaborator and "Ironwood Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "MediSphere Medical Research Center, LLC" are "Low Back Pain" (10 trials), "Osteoarthritis" (10 trials), "Gastroparesis" (5 trials), "Osteoarthritis, Knee" (5 trials) and "Chronic Pain" (4 trials). Many other conditions were trialed in "MediSphere Medical Research Center, LLC" in a lesser frequency.

Most popular intervention types in "MediSphere Medical Research Center, LLC" are "Drug" (91 trials), "Other" (13 trials), "Biological" (10 trials), "Behavioral" (2 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (52 trials), "Relamorelin" (4 trials), "Buprenorphine" (3 trials), "Fenofibrate" (3 trials) and "Ozanimod" (3 trials). Other intervention names were less common.

The vast majority of trials in "MediSphere Medical Research Center, LLC" are 95 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "MediSphere Medical Research Center, LLC". undefined are not yet recruiting, 8 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 66 completed trials in MediSphere Medical Research Center, LLC, undefined suspended trials, and 20 terminated clinical trials to date.

Out of the total trials that were conducted in MediSphere Medical Research Center, LLC, 0 "Phase 1" clinical trials were conducted, 25 "Phase 2" clinical trials and 75 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".